AI-Assisted Ophthalmic Imaging For Early Detection of Neurodegenerative Diseases

Artificial intelligence (AI) plays a promising role in ophthalmic imaging by providing innovative, non-invasive tools for the early detection of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Since early diagnosis is crucial for slowing disease progression and improving patient outcomes, leveraging AI-assisted ophthalmic imaging retinal imaging can enhance detection accuracy and clinical decision-making. AI-assisted ophthalmic imaging retinal imaging enhances the early identification of neurodegenerative diseases by detecting microscopic structural and vascular changes in the retina.